Reported 13 days ago
JPMorgan has reduced its price target for Colgate-Palmolive (NYSE:CL) from $95 to $88 while keeping an Overweight rating ahead of the company's Q3 earnings report on October 31, 2025. The consumer goods giant has experienced a nearly 14% decline, prompting analysts to express concern over its performance. Despite maintaining full-year guidance, Colgate-Palmolive anticipates organic sales growth at the lower end of the 2% to 4% range due to weaker category trends. Positive factors like favorable foreign exchange conditions and improved tariff-related costs provide some support, but challenges remain. The company continues to grow dividends, offering a yield of 2.66%.
Source: YAHOO